Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Anti-infectives
Proteins
Small molecule therapeutics
Vaccines
Molecular diagnostics
Immunotherapy
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 187
On the market: 30
Description:
F. Hoffmann-La Roche AG is a research-based healthcare company. Roche's operating businesses are organized into two divisions: pharmaceuticals and diagnostics. The pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. The diagnostics division consists of four business areas: diabetes care, molecular diagnostics, professional diagnostics, and tissue diagnostics. The company offer an extensive product portfolio featuring cutting-edge instruments and reagents...
